Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.
Transl Oncol. 2018 Feb;11(1):168-174. doi: 10.1016/j.tranon.2017.12.001. Epub 2017 Dec 28.
Transl Oncol. 2018.
PMID: 29289845
Free PMC article.
Oncolytic virotherapy for head and neck cancer: current research and future developments.
Malhotra A, Sendilnathan A, Old MO, Wise-Draper TM.
Malhotra A, et al. Among authors: sendilnathan a.
Oncolytic Virother. 2015 Jul 20;4:83-93. doi: 10.2147/OV.S54503. eCollection 2015.
Oncolytic Virother. 2015.
PMID: 27512673
Free PMC article.
Review.
Item in Clipboard
Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
Agarwal R, Sendilnathan A, Siddiqi NI, Gulati S, Ghose A, Xie C, Olowokure OO.
Agarwal R, et al. Among authors: sendilnathan a.
J Gastrointest Oncol. 2016 Dec;7(6):996-1003. doi: 10.21037/jgo.2016.09.10.
J Gastrointest Oncol. 2016.
PMID: 28078124
Free PMC article.
Item in Clipboard
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Gill DM, Stenehjem DD, Parikh K, Merriman J, Sendilnathan A, Agarwal AM, Hahn AW, Gupta S, Tantravahi SK, Samlowski WE, Agarwal N.
Gill DM, et al. Among authors: sendilnathan a.
Ecancermedicalscience. 2016 Sep 29;10:676. doi: 10.3332/ecancer.2016.676. eCollection 2016.
Ecancermedicalscience. 2016.
PMID: 27729941
Free PMC article.
Item in Clipboard
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Lam ET, Wong MK, Agarwal N, Redman BG, Logan T, Gao D, Flaig TW, Lewis K, Poust J, Monk P, Jarkowski A, Sendilnathan A, Bolden M, Kuzel TM, Olencki T.
Lam ET, et al. Among authors: sendilnathan a.
J Immunother. 2014 Sep;37(7):360-5. doi: 10.1097/CJI.0000000000000044.
J Immunother. 2014.
PMID: 25075565
Free PMC article.
Item in Clipboard
Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods.
Malek E, Sendilnathan A, Yellu M, Petersen A, Fernandez-Ulloa M, Driscoll JJ.
Malek E, et al. Among authors: sendilnathan a.
Blood Cancer J. 2015 Jul 24;5(7):e326. doi: 10.1038/bcj.2015.51.
Blood Cancer J. 2015.
PMID: 26207787
Free PMC article.
No abstract available.
Item in Clipboard
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N, Smith EP, Takeuchi K, Senda T, Kofuji S, Sasaki AT.
Naffouje R, et al. Among authors: sendilnathan a.
Cancers (Basel). 2019 Sep 11;11(9):1346. doi: 10.3390/cancers11091346.
Cancers (Basel). 2019.
PMID: 31514446
Free PMC article.
Review.
Item in Clipboard
Cite
Cite